Results 131 to 140 of about 487,201 (201)

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial. [PDF]

open access: yesBlood Cancer J
Koschmieder S   +27 more
europepmc   +1 more source

NGS and emerging molecular scenarios in chronic myeloproliferative neoplasms: a case of double mutated polycythemia vera. [PDF]

open access: yesAnn Hematol
Cerchiara E   +9 more
europepmc   +1 more source

Prevalence, incidence, and risk factors of secondary malignancies in patients with polycythemia vera: a real-world study. [PDF]

open access: yesBlood Adv
Pemmaraju N   +11 more
europepmc   +1 more source

Polycythemia Vera with Incidental Large Aortic Aneurysm and Giant Cell Arteritis: Case Report. [PDF]

open access: yesClin Med Insights Case Rep
Obaid K   +8 more
europepmc   +1 more source

JAK Inhibitor-Induced Improvement of IgA Nephropathy in a Patient With Polycythemia Vera: A Case Report. [PDF]

open access: yesKidney Med
Takahashi-Kobayashi M   +5 more
europepmc   +1 more source

Optimizing Polycythemia Vera Management Through a Collaborative Care Model Between Leukemia Oncologists and an Integrated Specialty Pharmacy. [PDF]

open access: yesJ Adv Pract Oncol
Yogarajah U   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy